EN DE
STOCK COMPARISON

Jenscare Scientific Co vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how Jenscare Scientific Co (9877) and Abbott Laboratories (ABT) compare, as of Aug 17, 2026.

As of Aug 17, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Jenscare Scientific Co trades at HK$7.46 versus a fair value of HK$1.19 (-84%), while Abbott Laboratories trades at $111 versus $74.79 (-33%).
Jenscare Scientific Co
9877.HK · HKD · Health Care
-84%
upside to fair value
overvalued
PriceHK$7.46
Fair ValueHK$1.19
Quality44/100
Abbott Laboratories
ABT · USD · Health Care
-33%
upside to fair value
overvalued
Price$111
Fair Value$74.79
Quality67/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Jenscare Scientific CoAbbott Laboratories
Valuation
P/E (TTM)27.7×
4.17×P/S (TTM)3.89×
0.48×P/B3.36×
EV/EBITDA15.1×
PEG1.47×
Dividend yield2.7%
Profitability
Net margin14%
-121%Operating margin13%
-32%Return on equity12%
-15%Return on assets6%
Growth
0%Revenue growth (YoY)8%
Avg. growth/yr (3Y)0.5%
Avg. growth/yr (5Y)5.1%
Balance & size
0.02×Debt / equity0.19×
$377MMarket cap$175B
weakGrowth qualityhealthy

Abbott Laboratories leads: 2 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Jenscare Scientific Coof which business quality 44 · market factors 32 Abbott Laboratoriesof which business quality 66 · market factors 55
ProfitabilityMargins and returns on capital today
0
50
Quality GrowthAre margins and returns improving?
50
47
CashflowEarnings quality: real cash, not paper profit
0
71
Fin. StrengthBalance sheet, leverage, solvency risk
99
80
InvestmentDisciplined investing over empire-building
93
65
Low VolatilityCalm price path (market factor)
55
83
MomentumPrice trend over the last 3–12 months (market factor)
28
45
52W MomentumDistance to the 52-week high (market factor)
14
38
Net IssuanceBuybacks instead of dilution
48
84

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Jenscare Scientific Co

Asset-BasedHK$1.27

1 of 1 models see the stock below the current price.

Abbott Laboratories

DCF Models$73.01
Earnings-Based$29.42
Dividend Discount$39.73
Multiples$70.72
Asset-Based$20.05
Growth DCF$67.02
Economic Profit$37.49
Growth Earnings$70.25

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Jenscare Scientific Co
Bear HK$0.79Fair Value HK$1.19Bull HK$1.49
HK$7.46 = current price (white tick)
Abbott Laboratories
Bear $51.13Fair Value $74.79Bull $94.43
$111 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Jenscare Scientific Co · Health Care

Quality score44 · below median
Fair value upside-84% · bottom 25%

Abbott Laboratories · Health Care

Quality score67 · Top 25%
Fair value upside-33% · below median

Bottom line

As of Aug 17, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Jenscare Scientific Co trades at HK$7.46 versus a fair value of HK$1.19 (-84%), while Abbott Laboratories trades at $111 versus $74.79 (-33%).

Abbott Laboratories has the higher quality score (67/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.